Green Vision Biotechnology Corp. (GVBT) Financial Statements (2024 and earlier)

Company Profile

Business Address ROOMS 1804-06, 18/F, WING ON HOUSE
HONG KONG SAR, 00000
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 287 - Agricultural Chemicals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,7776,50733,253138,849231,54926,734
Cash and cash equivalents11,7776,50733,253138,849231,54926,734
Receivables23,02622,95522,64322,60923,41522,364
Inventory, net of allowances, customer advances and progress billings   2,6991,6741,969 
Inventory   2,6991,6741,969 
Other undisclosed current assets79,5663204201,1458201,822
Total current assets:114,36929,78259,015164,277257,75350,920
Noncurrent Assets
Property, plant and equipment939,9952,073,2112,081,1492,114,0752,124,5832,162,624
Intangible assets, net (including goodwill)814,577818,403813,518818,522814,948822,006
Intangible assets, net (excluding goodwill)814,577818,403813,518818,522814,948822,006
Other undisclosed noncurrent assets775772762846836820
Total noncurrent assets:1,755,3472,892,3862,895,4292,933,4432,940,3672,985,450
TOTAL ASSETS:1,869,7162,922,1682,954,4443,097,7203,198,1203,036,370
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities345,036349,516302,673352,953354,503322,177
Taxes payable16,87116,81911,90411,906 5,879
Employee-related liabilities20,52918,26013,35713,30013,14213,194
Accounts payable19,98719,92627,61227,57027,24227,272
Accrued liabilities287,649294,511249,800300,177314,119275,832
Due to related parties5,780,2845,797,2045,779,1625,772,8375,776,6685,745,866
Other liabilities266,179264,217263,340261,305256,809255,145
Other undisclosed current liabilities4,526,3934,427,7204,365,0314,361,6154,328,8614,127,723
Total current liabilities:10,917,89210,838,65710,710,20610,748,71010,716,84110,450,911
Noncurrent Liabilities
Total liabilities:10,917,89210,838,65710,710,20610,748,71010,716,84110,450,911
Equity
Equity, attributable to parent(9,048,176)(7,916,489)(7,755,762)(7,650,990)(7,518,721)(7,414,541)
Common stock160,790160,790160,790160,790160,790160,790
Additional paid in capital(282,209)(282,209)(282,209)(282,209)(282,209)(282,209)
Accumulated other comprehensive income (loss)(134,459)(157,334)(145,071)(159,890)(153,410)(155,163)
Accumulated deficit(8,792,298)(7,637,736)(7,489,272)(7,369,681)(7,243,892)(7,137,959)
Total equity:(9,048,176)(7,916,489)(7,755,762)(7,650,990)(7,518,721)(7,414,541)
TOTAL LIABILITIES AND EQUITY:1,869,7162,922,1682,954,4443,097,7203,198,1203,036,370

Income Statement (P&L) (USD)

6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
Revenues 410 80,21664,47310,528
Other income      
Cost of revenue  (209) (41,211)(32,753)(8,746)
Cost of goods and services sold    (41,211)  
Gross profit: 201 39,00531,7201,782
Operating expenses(130,355)(191,106)(117,768)(169,675)(138,610)(257,227)
Other operating expense, net
(Other Expenses)
  (21,408)    
Other undisclosed operating income (loss) 1,088,920    
Operating income (loss):(130,355)876,607(117,768)(130,670)(106,890)(255,445)
Interest and debt expense(1,541)(446)(1,835)(1,095)(510)(582)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (163,201)
Income (loss) from continuing operations:(131,896)876,161(119,603)(131,765)(107,400)(419,228)
Income (loss) before gain (loss) on sale of properties:(131,896)876,161(119,603)(131,765)(107,400)(415,663)
Income from discontinued operations      3,565
Other undisclosed net income 1,286,458    25,458
Net income (loss):1,154,562876,161(119,603)(131,765)(107,400)(390,205)
Other undisclosed net income (loss) attributable to parent(2,309,124)(1,024,625)125,9761,467133,056
Net loss attributable to parent:(1,154,562)(148,464)(119,591)(125,789)(105,933)(257,149)
Other undisclosed net income available to common stockholders, basic      3,565
Net loss available to common stockholders, diluted:(1,154,562)(148,464)(119,591)(125,789)(105,933)(253,584)

Comprehensive Income (USD)

6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
Net income (loss):1,154,562876,161(119,603)(131,765)(107,400)(390,205)
Other comprehensive income (loss)  12,263  (1,753)47,142
Comprehensive income (loss):1,154,562888,424(119,603)(131,765)(109,153)(343,063)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2,286,249)(1,049,151)14,831(504)4,97342,337
Comprehensive income (loss), net of tax, attributable to parent:(1,131,687)(160,727)(104,772)(132,269)(104,180)(300,726)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: